- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/133 - Amines, e.g. amantadine having hydroxy groups, e.g. sphingosine
Patent holdings for IPC class A61K 31/133
Total number of patents in this class: 562
10-year publication summary
42
|
50
|
41
|
50
|
54
|
62
|
62
|
52
|
54
|
8
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Insmed Incorporated | 207 |
14 |
NeuroDerm, Ltd. | 115 |
11 |
The Regents of the University of California | 18943 |
10 |
Dyve Biosciences, Inc. | 31 |
9 |
The Cleveland Clinic Foundation | 1591 |
8 |
University of Virginia Patent Foundation | 1470 |
6 |
The Johns Hopkins University | 5377 |
5 |
Ortho-nutra, LLC | 13 |
5 |
Vanda Pharmaceuticals, Inc. | 336 |
5 |
Emerald Health Pharmaceuticals Inc. | 17 |
5 |
Metanoi Therapeutics, Inc. | 6 |
5 |
Conopco, Inc. | 4644 |
4 |
Janssen Pharmaceutica N.V. | 3839 |
4 |
University of Florida Research Foundation, Inc. | 3883 |
4 |
Abela Pharmaceuticals, Inc. | 17 |
4 |
Hikma Pharmaceuticals LLC | 12 |
4 |
Hovione Scientia Limited | 136 |
4 |
OCuSOFT, Inc. | 158 |
4 |
Saint Louis University | 289 |
4 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
4 |
Other owners | 443 |